Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.
Cell Discov
; 6: 29, 2020.
Article
in En
| MEDLINE
| ID: mdl-32411384
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cell Discov
Year:
2020
Document type:
Article
Affiliation country:
Denmark
Country of publication:
United kingdom